↓ Skip to main content

Dopaminergic modulation of the reward system in schizophrenia: A placebo-controlled dopamine depletion fMRI study

Overview of attention for article published in European Neuropsychopharmacology, August 2013
Altmetric Badge

Mentioned by

facebook
1 Facebook page

Citations

dimensions_citation
24 Dimensions

Readers on

mendeley
117 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Dopaminergic modulation of the reward system in schizophrenia: A placebo-controlled dopamine depletion fMRI study
Published in
European Neuropsychopharmacology, August 2013
DOI 10.1016/j.euroneuro.2013.06.008
Pubmed ID
Authors

Fabiana da Silva Alves, Geor Bakker, Nicole Schmitz, Nico Abeling, Gregor Hasler, Johan van der Meer, Aart Nederveen, Lieuwe de Haan, Don Linszen, Therese van Amelsvoort

Abstract

The brain reward circuitry innervated by dopamine is critically disturbed in schizophrenia. This study aims to investigate the role of dopamine-related brain activity during prediction of monetary reward and loss in first episode schizophrenia patients.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 117 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
United States 1 <1%
Germany 1 <1%
South Africa 1 <1%
Unknown 113 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 20 17%
Student > Master 17 15%
Student > Bachelor 16 14%
Student > Ph. D. Student 16 14%
Student > Doctoral Student 8 7%
Other 19 16%
Unknown 21 18%
Readers by discipline Count As %
Psychology 28 24%
Neuroscience 23 20%
Medicine and Dentistry 9 8%
Agricultural and Biological Sciences 7 6%
Physics and Astronomy 3 3%
Other 14 12%
Unknown 33 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 March 2015.
All research outputs
#22,759,452
of 25,374,647 outputs
Outputs from European Neuropsychopharmacology
#1,927
of 2,571 outputs
Outputs of similar age
#187,805
of 211,133 outputs
Outputs of similar age from European Neuropsychopharmacology
#29
of 32 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,571 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.2. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 211,133 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 32 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.